03190nam0 2200601 i 450 TO0055410120251003044406.08846400070IT97-3272 20160422d1997 ||||0itac50 baitaitz01i xxxe z01nz01ncRDAcarrierItalia multinazionale 1996tendenze e protagonisti dell'internazionalizzazionericerca del CNEL6. rapporto R&P al Consiglio nazionale dell'economia e del lavoroa cura di Ruggero Cominotti, Sergio Mariottiprefazione di Giuseppe De RitaMilanoF. Angeli\1997!430 p.22 cmSegue: Allegati.Imprese multinazionaliItaliaFIRCFIC016576IImpreseInternazionalizzazioneItaliaFIRCFIC089060I338.88945IMPRESE A CAPITALE ITALIANO20IT/5422.6POLITICA ECONOMICA ITALIA 1989-2001RIT/5432.3GRANDE INDUSTRIA PRIVATA MULTINAZIONALI ITALIA 1989-2001RX033.7REPERTORI DI ENTI E ASSOCIAZIONIRMultinazionaliImprese internazionaliSocietà internazionaliSocietà multinazionaliAziende multinazionaliImprese multinazionaliMultinazionaliImprese multinazionaliImprese internazionaliImprese multinazionaliSocietà internazionaliImprese multinazionaliSocietà multinazionaliImprese multinazionaliAziende multinazionaliCominotti, RuggeroCFIV103836Mariotti, Sergio <1947- >UBOV026908R & P <s.c.r.l.>CFIV138262070425640CNELCFIV004803Conseil national de l'économie et du travailCFIV134009CNELEconomy and labour national councilCFIV134731CNELItalia : Consiglio nazionale dell'economia e del lavoroCFIV156625CNELConsiglio nazionale dell'economia e del lavoroCFIV158538CNELConseil national de l'économie et du travailCFIV134009CNELEconomy and labour national councilCFIV134731CNELItalia : Consiglio nazionale dell'economia e del lavoroCFIV156625CNELConsiglio nazionale dell'economia e del lavoroCFIV158538CNELR [e] P-Ricerche e progetti <s.c.r.l.>CFIV158465R & P <s.c.r.l.>R [e] P <s.c.r.l.>CFIV159619R & P <s.c.r.l.>ITIT-00000020160422IT-BN0095 NAP 01POZZO LIB.Vi sono collocati fondi di economia, periodici di ingegneria e scienze, periodici di economia e statistica e altri fondi comprendenti documenti di economia pervenuti in dono. TO00554101Biblioteca Centralizzata di Ateneo1 v.1 v. 01POZZO LIB.ECON MON 8083 0101 0000096865E VMA 1 v. (Precedente collocazione: GUERRAZZI B 1035)B 2008032720080327 01Italia multinazionale 199667322UNISANNIO04002nam 22006495 450 991076359540332120251008140500.03-031-35811-210.1007/978-3-031-35811-1(MiAaPQ)EBC30881075(Au-PeEL)EBL30881075(DE-He213)978-3-031-35811-1(CKB)28817574700041(EXLCZ)992881757470004120231110d2023 u| 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierPharmaceutical Formulations for Older Patients /edited by Mine Orlu, Fang Liu1st ed. 2023.Cham :Springer International Publishing :Imprint: Springer,2023.1 online resource (294 pages)AAPS Advances in the Pharmaceutical Sciences Series,2210-738X ;51Print version: Orlu, Mine Pharmaceutical Formulations for Older Patients Cham : Springer International Publishing AG,c2023 9783031358104 Part 1: Patient-Centric Considerations.-Medicine Optimisation in Older -- Acceptability of drug formulations in older patients and effect on patient adherence -- Geriatric biopharmaceutics -- Excipient safety in older adults -- Part 2: Pharmaceutical Formulations Development for older Patients -- Oral and oromucosal formulation development and in vitro characterisation – patient-centric approaches for older adults -- Pulmonary drug delivery systems for older people -- Transdermal drug delivery systems for older patients -- Part 3 :Advanced Drug Delivery Systems for Older Patients -- Advanced oral drug delivery systems for older patients -- The ageing microbiome, pharmaceutical considerations and therapeutic opportunities -- Application of 3D printing in geriatric medicines, -- Application of electrospraying and advanced fabrication methods in geriatric medicines -- Vaccine development for older patients.Pharmaceutical formulation design affects patient acceptability/adherence and pharmacokinetics of the drug. This is particularly important for older patients because of the physiological changes due to ageing and clinical/social circumstances related to medicine taking. This book provides a comprehensive review in the design of formulations to meet the needs of older patients. An overview of the key clinical, social and pharmaceutical factors affecting medication optimization, safety and acceptability in older adults is included, followed by patient-centric considerations including regulatory requirements, dosage form design and human factor studies. Advanced pharmaceutical technologies are discussed for their potential use in older adults such as 3D printing, long-acting oral formulations and novel vaccine technologies. The unique focus of the book will be of interest to pharmaceutical scientists in both industry and academia in searching for better formulations for older patients.AAPS Advances in the Pharmaceutical Sciences Series,2210-738X ;51Drug delivery systemsPharmaceutical chemistryPharmacologyMedicineResearchBiologyResearchDrug DeliveryPharmaceuticsPharmacologyBiomedical ResearchDrug delivery systems.Pharmaceutical chemistry.Pharmacology.MedicineResearch.BiologyResearch.Drug Delivery.Pharmaceutics.Pharmacology.Biomedical Research.615.70846Orlu Mine1439068Liu Fang674440MiAaPQMiAaPQMiAaPQBOOK9910763595403321Pharmaceutical Formulations for Older Patients3601295UNINA